The oncogenic EGFR signaling in NSCLC engages the activation of downstream effectors such as AKT-mTOR, ERK and STAT3 to promote cell proliferation, cell survival, and tumor growth [4, 9, 31, 32]. The gene discussed is MTOR; the disease is neoplasm.